Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

01 Jul 2024 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Tentative Approval for Bosutinib Tablets, 100 mg and 500 mg. The company has enclosed its press release.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..